Is the 6MWT still the best endpoint for Pompe disease clinical trials?
The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are calling for change.
Stay updated with breaking news from Event Conception. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are calling for change.
Canada’s pharma industry registered a 17.4% rises in IT hiring activity in February 2022, according to GlobalData
Certain big pharma companies have reconsidered their clinical trial footprint in Russia. Clinical Trials Arena dives into trends.
VivaVision Biotech has reported positive topline data from a Phase II clinical trial of VVN001 in dry eye disease patients.
The Icahn School of Medicine at Mount Sinai has commenced a Phase I trial of an egg-based Covid-19 vaccine in healthy adult subjects.